| RS1004620245 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS1004640402 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A1-related disorder, COL4A1-related disorder |
| RS1004649901 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1004651681 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS1004658892 |
FITM2
|
Health Risk |
Pathogenic |
Siddiqi syndrome, Siddiqi syndrome |
| RS1004772663 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Needles syndrome, Oto-palato-digital syndrome |
| RS1004775935 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1004779078 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1004855056 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1004898711 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1004936255 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1004943548 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1004968910 |
SHOC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spermatogenic failure 75, SHOC1-related condition |
| RS1004972253 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Polymerase proofreading-related adenomatous polyposis |
| RS1004988273 |
HMBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS1005010589 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1005025657 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 2 |
| RS1005027685 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1005040113 |
TLR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Herpes simplex encephalitis, susceptibility to |
| RS1005071009 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1005081558 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1005082526 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1005120343 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1005130980 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 26 |
| RS1005167119 |
DTYMK
|
Health Risk |
Pathogenic |
Neurodegeneration, childhood-onset |
| RS1005167452 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |
| RS1005235415 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1005244744 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1005250117 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS1005271380 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1005334519 |
UNC13D
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1005361810 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1005382525 |
TAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS1005389790 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome |
| RS1005396685 |
SLC12A6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1005444925 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1005458732 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1005463281 |
OBSCN
|
Health Risk |
Likely pathogenic |
— |
| RS1005498417 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS1005521110 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1005542482 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS1005543441 |
CEP57
|
Health Risk |
Conflicting classifications of pathogenicity |
Mosaic variegated aneuploidy syndrome 2, Inborn genetic diseases |
| RS1005550058 |
RAPSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS1005568368 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1005570619 |
PTPRQ
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 84A, Autosomal recessive nonsyndromic hearing loss 84A |
| RS1005618432 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1005670966 |
AFG3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1005686810 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1005687078 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS1005694756 |
OTOF
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive |
| RS1005703927 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1005714777 |
WFS1
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Monogenic diabetes, Wolfram syndrome 1 |
| RS1005731602 |
THPO
|
Health Risk |
Likely pathogenic |
— |
| RS1005738588 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1005753 |
PADI2
|
Health Risk |
association |
Rheumatoid arthritis, Abnormal pulmonary interstitial morphology |
| RS1005792910 |
ACE
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular dysgenesis of genetic origin, Renal tubular dysgenesis of genetic origin |
| RS1005810029 |
ADNP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1005844306 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1005850234 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1005852754 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1005930319 |
SZT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1005934435 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1005937012 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS1005957166 |
EDARADD
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type |
| RS1005962230 |
ATF6
|
Health Risk |
Pathogenic |
— |
| RS1005998005 |
MANF
|
Health Risk |
Likely pathogenic |
Diabetes, deafness |
| RS1006014823 |
COL4A6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1006015882 |
HSPA9
|
Health Risk |
Likely pathogenic |
— |
| RS1006060877 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1006063188 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease axonal type 2C |
| RS1006097259 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1006109370 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1006150317 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1006158872 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1006218944 |
ANO6
|
Health Risk |
Likely pathogenic |
Malignant tumor of esophagus, Malignant tumor of esophagus |
| RS1006236175 |
CLN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS1006246556 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1006249036 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS1006261196 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1006276729 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, FG syndrome |
| RS1006294051 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1006328489 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1006352232 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1006357203 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1006366530 |
TRIO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1006368552 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1006397889 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Radioulnar synostosis, Craniosynostosis 7 |
| RS1006425986 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1006433886 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1006435630 |
BBS9
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome 9 |
| RS1006463439 |
NOBOX
|
Health Risk |
Likely pathogenic |
Premature ovarian failure, Premature ovarian failure |
| RS1006465697 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Autism spectrum disorder |
| RS1006524651 |
LMAN1
|
Health Risk |
Pathogenic |
Factor V and factor VIII, combined deficiency of |
| RS1006530719 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1006561792 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1006611330 |
SCN11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy type 7, Familial episodic pain syndrome with predominantly lower limb involvement |
| RS10066808 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 24 |
| RS1006687669 |
SMO
|
Health Risk |
Pathogenic |
Congenital hypothalamic hamartoma syndrome, Congenital hypothalamic hamartoma syndrome |
| RS10066882 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS1006688520 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |